Plaintiff Permitted to Amend Off-Label Promotion Claims in Risperdal Action



DOCUMENTS
  • Order


TYLER, Texas — A Texas federal judge has allowed a plaintiff to amend his off-label promotion claims against generic Risperdal makers to specify the actions the drug makers allegedly took to influence doctors to prescribe the drug for off-label uses.

In a Sept. 19 order, Judge Robert W. Schroeder III adopted a magistrate judge’s recommendation that the off-label claims — while not preempted or barred by the learned intermediary doctrine — were inadequately pled.

Malcom Wydermyer alleged his ingestion of Risperdal and generic risperidone to treat his psychosis and schizophrenia caused him to develop gynecomastia. He further alleged that the …

FIRM NAMES
  • Baker Donelson Bearman Caldwell & Berkowitz
  • Haley & Olson
  • Morrison Mahoney
  • Morrison Mahoney
  • Naman, Howell, Smith & Lee
  • Scott Douglass & McConnico





UPCOMING CONFERENCES




HarrisMartin's Camp Lejeune Water Contamination Litigation Conference: What Comes Next?

September 15, 2022 - Houston, TX
Four Seasons Hotel Houston

MORE DETAILS



HarrisMartin's Midwest Asbestos Litigation Conference

September 21, 2022 - St. Louis, MO
Four Seasons Hotel, St. Louis

MORE DETAILS